Anastrozole Tablet, Coated
Product Images NDC 72789-342

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Anastrozole (NDC 72789-342). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789342 Label (72789342)

Label for Anastrozole USP 1 mg coated tablets, 15 tablets per container. The label includes a warning to keep out of reach of children and a note that the product is Rx only. The labeler is PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK. Additional information includes the National Drug Code (NDC) 72789-342-15, lot number C29045, and expiration date 12/2024.*

FDA Label Image

Structured Formula For Anastrozole Tablets (A4544840 7708 43a7 95ec 7482241e67a3 01)

Chemical structure of the active ingredient anastrozole, showing its ring system and functional groups as represented in a molecular diagram.*

FDA Label Image

Structured Formula For Anastrozole Tablets (A4544840 7708 43a7 95ec 7482241e67a3 02)

A line graph comparing disease-free survival over 90 months between anastrozole and tamoxifen treatments. The x-axis represents disease-free survival in months, and the y-axis shows the proportion of patients alive and disease-free. Two lines, one dashed for anastrozole and one solid for tamoxifen, illustrate patient outcomes alongside a table of patient numbers at risk over time for each treatment group.*

FDA Label Image

Structured Formula For Anastrozole Tablets (A4544840 7708 43a7 95ec 7482241e67a3 03)

A line graph comparing disease-free survival over months between two treatments: anastrozole and tamoxifen. The x-axis represents disease-free survival in months (0 to 90), and the y-axis shows the proportion of patients alive and disease-free (0.0 to 1.0). Two curves, one dashed for anastrozole and one solid for tamoxifen, track patient survival. Below, a table lists the number of patients at risk for each treatment over time.*

FDA Label Image

Anastrozole Tablets (A4544840 7708 43a7 95ec 7482241e67a3 04)

A Kaplan-Meier curve comparing the proportion of patients event-free over time (in months) between randomized treatments with Anastrozole and Tamoxifen. The x-axis shows time to event in months up to 120, and the y-axis shows the proportion event-free, truncated between 0.50 and 1.00 for clarity. The number of patients at risk for each treatment is listed below the x-axis for selected months.*

FDA Label Image

Anastrozole Tablets (A4544840 7708 43a7 95ec 7482241e67a3 05)

Kaplan-Meier curves showing the proportion of event-free patients over time (up to 120 months) comparing Anastrozole and Tamoxifen treatments. The graph includes two descending lines representing these treatments and a table indicating the number of patients at risk at various time points.*

FDA Label Image

Structured Formula For Anastrozole Tablets (A4544840 7708 43a7 95ec 7482241e67a3 06)

A survival curve graph comparing the proportion of patients not progressing over time in months between randomized treatments with Anastrozole and Tamoxifen. The x-axis represents time to progression in months, and the y-axis shows the proportion not progressing. The chart includes a table of patient numbers at risk for each treatment at various time points.*

FDA Label Image

Structured Formula For Anastrozole Tablets (A4544840 7708 43a7 95ec 7482241e67a3 07)

A Kaplan-Meier curve showing the proportion not progressing over time in months for randomized treatment with anastrozole and tamoxifen. The graph plots proportion not progressing (y-axis) against time to progression in months (x-axis) with two lines representing anastrozole (solid) and tamoxifen (dashed). The number of patients at risk is listed below the time axis at various months.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.